يعرض 1 - 4 نتائج من 4 نتيجة بحث عن '"CLEAR study"', وقت الاستعلام: 1.50s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Lenvatinib plus pembrolizumab versus sunitinib for advanced renal cell carcinoma: Japanese patients from the CLEAR study

    المؤلفون: Masatoshi Eto, Toshio Takagi, Go Kimura, Satoshi Fukasawa, Satoshi Tamada, Yuji Miura, Mototsugu Oya, Naoto Sassa, Satoshi Anai, Masahiro Nozawa, Hideki Sakai, Rodolfo Perini, Wataru Yusa, Hiroki Ikezawa, Tomoyuki Narita, Yoshihiko Tomita

    المصدر: Cancer Medicine, Vol 12, Iss 6, Pp 6902-6912 (2023)

    مصطلحات موضوعية: CLEAR study, Japanese patients, lenvatinib, pembrolizumab, renal cell carcinoma, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    العلاقة: https://doaj.org/toc/2045-7634Test

    الوصول الحر: https://doaj.org/article/8c1591921a074d1ba5b9e9d36660eacfTest

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    E-250 eTICI 2b67–3 is an optimal reperfusion benchmark and is achieved on the first pass in two out of every three cases in the NeVa clear study

    المؤلفون: Yoo, A, Geyik, S, Lopes, Demetrius

    المصدر: All Other Contributions

    مصطلحات موضوعية: Rapid reperfusion, thrombectomy, first pass effect, FPE, expanded Treatment in Cerebral Ischemia, eTCI, CLEAR study, NeVa device, Neurosurgery

    العلاقة: https://institutionalrepository.aah.org/allother/675Test

    الإتاحة: https://doi.org/10.1136/jnis-2023-SNIS.349Test
    https://institutionalrepository.aah.org/allother/675Test

    View record in BASE

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Primary results from the CLEAR study of the safety and effectiveness of the NeVa stent retriever for large vessel thrombectomy

    المؤلفون: Yoo, Albert J, Geyik, Serdar, Lopes, Demetrius

    المصدر: All Other Contributions

    مصطلحات موضوعية: CLEAR study, NeVa stent retriever, large vessel thrombectomy, Neurosurgery

    العلاقة: https://institutionalrepository.aah.org/allother/550Test; https://libkey.io/libraries/1712/10.1161/str.54.suppl_1.WMP87Test

    الإتاحة: https://doi.org/10.1161/str.54.suppl_1.WMP87Test
    https://institutionalrepository.aah.org/allother/550Test

    View record in BASE

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Health-related quality-of-life outcomes in patients with advanced renal cell carcinoma treated with lenvatinib plus pembrolizumab or everolimus versus sunitinib (CLEAR): a randomised, phase 3 study

    المؤلفون: Motzer, Robert, Porta, Camillo, Alekseev, Boris, Rha, Sun Young, Choueiri, Toni K, Mendez-Vidal, Maria Jose, Hong, Sung-Hoo, Kapoor, Anil, Goh, Jeffrey C, Eto, Masatoshi, Bennett, Lee, Wang, Jinyi, Pan, Jie Janice, Saretsky, Todd L, Perini, Rodolfo F, He, Cixin Steven, Mody, Kalgi, Cella, David

    المساهمون: Motzer, Robert, Porta, Camillo, Alekseev, Bori, Rha, Sun Young, Choueiri, Toni K, Mendez-Vidal, Maria Jose, Hong, Sung-Hoo, Kapoor, Anil, Goh, Jeffrey C, Eto, Masatoshi, Bennett, Lee, Wang, Jinyi, Pan, Jie Janice, Saretsky, Todd L, Perini, Rodolfo F, He, Cixin Steven, Mody, Kalgi, Cella, David

    مصطلحات موضوعية: CLEAR study, lenvatinib, pembrolizumab, sunitinib, progression-free survival, overall survival, advanced renal cell carcinoma

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35489363; info:eu-repo/semantics/altIdentifier/wos/WOS:000831830800022; volume:23; issue:6; firstpage:768; lastpage:780; numberofpages:13; journal:THE LANCET ONCOLOGY; https://hdl.handle.net/11586/464740Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85131115613

    الإتاحة: https://doi.org/10.1016/s1470-2045Test(22)00212-1
    https://hdl.handle.net/11586/464740Test

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث